Recent Advances in the Development of Tetrazine Ligation Tools for Pretargeted Nuclear Imaging
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 7,25 MB, PDF-dokument
Tetrazine ligation has gained interest as a bio-orthogonal chemistry tool within the last decade. In nuclear medicine, tetrazine ligation is currently being explored for pretargeted approaches, which have the potential to revolutionize state-of-the-art theranostic strategies. Pretargeting has been shown to increase target-to-background ratios for radiopharmaceuticals based on nanomedicines, especially within early timeframes. This allows the use of radionuclides with short half-lives which are more suited for clinical applications. Pretargeting bears the potential to increase the therapeutic dose delivered to the target as well as reduce the respective dose to healthy tissue. Combined with the possibility to be applied for diagnostic imaging, pretargeting could be optimal for theranostic approaches. In this review, we highlight efforts that have been made to radiolabel tetrazines with an emphasis on imaging.
Originalsprog | Engelsk |
---|---|
Artikelnummer | 685 |
Tidsskrift | Pharmaceuticals |
Vol/bind | 15 |
Udgave nummer | 6 |
Antal sider | 25 |
ISSN | 1424-8247 |
DOI | |
Status | Udgivet - 2022 |
Bibliografisk note
Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk
ID: 315251307